Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: Results of a population-based cross-sectional Norwegian Survey

Contraception

Volumn 66, Issue 1, 2002, Pages 7-13

  Graff Iversen, Sidsel ^a   Tonstad, Serena ^b  

^a National Health Screening Services   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cardiovascular disease; HDL cholesterol; Hormones; Intrauterine device; Progestogen; Triglycerides

Indexed keywords

GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVONORGESTREL; LYNESTRENOL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LIFESTYLE; OUTCOMES RESEARCH; POPULATION RESEARCH; QUALITY OF LIFE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036348674     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(02)00311-6     Document Type: Article

References (23)

1. Development of risk factors for cardiovascular disease among women from adolescence to older ages
2. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
3. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
4. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial
5. Medroxyprogesterone acetate antagonizes the inhibitory effects of conjugated equine estrogen on coronary artery atherosclerosis
6. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study
7. Oral progestogen-only contraceptives and cardiovascular risk: Results from the Transnational Study on Oral Contraceptives and the Health of Young Women
8. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism
9. A prospective, one-year study on the effects of two long-acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum lipids and lipoprotein levels
10. The cardiovascular disease study in Norwegian counties. Background and organization
11. Agreement of self-reported use of menopausal replacement therapy with physicians reports
12. Androgen and progestagen effects on plasma lipids
13. 2) and postheparin plasma hepatic lipase activity
14. A study on the effects of Norplant implantable contraceptive on lipid, lipoprotein, and apolipoprotein metabolism in Singaporean women
15. Special Programme of Research, Development, and Research Training in Human Reproduction. Task Force on Long-acting Systemic Agents for Fertility Regulation. Study of the effects of the implantable contraceptive Norplant on lipid and lipoprotein metabolism
16. Sustained intrauterine release of levonorgestrel over five years
17. Serum lipids and high-density lipoprotein cholesterol in women on long-term sustained low-dose IUD treatment with levonorgestrel
18. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use
19. Metabolism of lynestrenol: Characterization of 3-hydroxylation using rabbit liver microsomes in vitro
20. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes
21. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: The follow-up study of the Lipid Research Clinic's Prevalence Study
22. Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: Twenty-year follow-up of the Donodo-Tel Aviv Prospective Coronary Artery Disease Study
23. Effects of contraceptive estrogen and progestin on the atherogenic potential of plasma LDLs in cynomolgus monkeys